There is evidence from a previous meta-analysis that GLP-1RA confer a similar reduction in MACE in both sexes, whereas SGLT-2 inhibitors reduce the risk of MACE more in men than in women [31]
We don't know the long term ramifications
Everyone's biology is different, so your timeline may vary
DPP-4 inhibitors: DPP-4 inhibitors work by inhibiting the activity of dipeptidyl peptidase-4 (DPP-4), which reduces the breakdown and inactivation of the incretin GLP-1 (glucagon-like peptide-1), leading to increased endogenous levels of GLP-1
Left panel (Mechanism of Action & Pharmacodynamics) : Imipramine inhibits the serotonin transporter (SERT) and norepinephrine transporter (NET), resulting in increased synaptic concentrations of serotonin and norepinephrine (dual monoamine reuptake inhibition)
Confirm credentialing and licensure on the brand's own site, and treat those checks as standard due diligence for any telehealth weight service